Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Cunningham Kenneth, Director. Officer active across 1 company, notably Verona Pharma plc. Cumulatively, 3 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €9k. Activity tracked since 4 May 2021. The latest transaction was filed on 1 August 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Kenneth Cunningham is a Board Member at Verona Pharma plc. He plays an important role in the governance of the company, providing his expertise and strategic advice. His commitment to best practices in corporate governance contributes to the strength and transparency of the company's operations. He is involved in key decision-making that influences the future direction of the company.